Scheinfeld N «A comprehensive review and evaluation of the side effects of the tumor necrosis factor blockers etanercept, infliximab and adalimumab». J Dermatolog Treat, 15, 5, setembre 2004, pàg. 280–94. DOI: 10.1080/09546630410017275. PMID: 15370396.
«Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases». Nat. Med., 9, 10, octubre 2003, pàg. 1245–50. DOI: 10.1038/nm939. PMID: 14520364.
«Cutting edge: anti-tumor necrosis factor therapy in rheumatoid arthritis inhibits memory B lymphocytes via effects on lymphoid germinal centers and follicular dendritic cell networks». J. Immunol., 180, 2, gener 2008, pàg. 688–92. DOI: 10.4049/jimmunol.180.2.688. PMID: 18178805.
«Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors». Acta Derm. Venereol., 89, 6, novembre 2009, pàg. 595–600. DOI: 10.2340/00015555-0747. PMID: 19997689.
Korneev, KV; Atretkhany, KN; Drutskaya, MS; Grivennikov, SI; Kuprash, DV; Nedospasov, SA «TLR-signaling and proinflammatory cytokines as drivers of tumorigenesis.». Cytokine, 89, gener 2017, pàg. 127–135. DOI: 10.1016/j.cyto.2016.01.021. PMID: 26854213.
«Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent». N. Engl. J. Med., 345, 15, octubre 2001, pàg. 1098–104. DOI: 10.1056/NEJMoa011110. PMID: 11596589.
«Invasive fungal infections in pediatric patients treated with tumor necrosis alpha (TNF-α) inhibitors». Mycoses, 60, 4, octubre 2016, pàg. 222–229. DOI: 10.1111/myc.12576. PMID: 27766695.
«TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.». Neurology, 53, 3, 11-08-1999, pàg. 457–65. DOI: 10.1212/WNL.53.3.457. PMID: 10449104.
Napolitano, M; Balato, N; Ayala, F; Cirillo, T; Balato, A «Multiple sclerosis following anti-tumor necrosis factor-alpha therapy for psoriasis: first case in Italy?». Giornale Italiano di Dermatologia e Venereologia, 153, 4, agost 2018, pàg. 567–572. DOI: 10.23736/S0392-0488.17.04992-6. PMID: 25692775.
L. Gómez Vicente et al. "Relapse in a paucisymptomatic form of multiple sclerosis in a patient treated with nivolumab", Neuro Oncol (2016) 18 (suppl 4): iv25. doi:10.1093/neuonc/now188.085
«Autoimmune encephalitis in humans: how closely does it reflect multiple sclerosis?». Acta Neuropathologica Communications, 3, 1, Dec 2015, pàg. 80. DOI: 10.1186/s40478-015-0260-9. PMC: 4670499. PMID: 26637427.
Rana Alnasser Alsukhni, Ziena Jriekh and Yasmin Aboras, 2016. "Adalimumab Induced or Provoked MS in Patient with Autoimmune Uveitis: A Case Report and Review of the Literature." Case Reports in Medicine, Volume 2016 (2016), Article ID 1423131, doi https://dx.doi.org/10.1155/2016/1423131
Lassman Hans «Acute disseminated encephalomyelitis and multiple sclerosis». Brain, 133, 2, Feb 2010, pàg. 317–319. DOI: 10.1093/brain/awp342. PMID: 20129937.
«The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-gamma». Critical Care Medicine, 34, 7, juliol 2006, pàg. 1874–82. DOI: 10.1097/01.CCM.0000221921.71300.BF. PMID: 16715036.
«Curcumin protects against radiation-induced acute and chronic cutaneous toxicity in mice and decreases mRNA expression of inflammatory and fibrogenic cytokines». Int. J. Radiat. Oncol. Biol. Phys., 65, 3, juliol 2006, pàg. 890–8. DOI: 10.1016/j.ijrobp.2006.03.025. PMID: 16751071.
«Effects of curcumin on tumour necrosis factor-alpha and interleukin-6 in the late phase of experimental acute pancreatitis». J Vet Med a Physiol Pathol Clin Med, 53, 1, febrer 2006, pàg. 49–54. DOI: 10.1111/j.1439-0442.2006.00786.x. PMID: 16411910.
«Alkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effects». J. Biol. Chem., 281, 20, maig 2006, pàg. 14192–206. DOI: 10.1074/jbc.M601074200. PMID: 16547349.
Vilcek, J «First demonstration of the role of TNF in the pathogenesis of disease.». Journal of Immunology, 181, 1, 01-07-2008, pàg. 5–6. DOI: 10.4049/jimmunol.181.1.5. PMID: 18566362.
«Randomized double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.». Lancet, 344, 8930, octubre 1994, pàg. 1105–10. DOI: 10.1016/S0140-6736(94)90628-9. PMID: 7934491.
doi.org
Sinah Engel et al., PPMS onset upon adalimumab treatment extends the spectrum of anti-TNF-α therapy-associated demyelinating disorders, January 2, 2020 [1]
Alicja Kalinowska-Lyszczarz, Mahboobeh Fereidan-Esfahani, Yong Guo, "Pathological findings in central nervous system demyelination associated with infliximab", https://doi.org/10.1177/1352458519894710
Scheinfeld N «A comprehensive review and evaluation of the side effects of the tumor necrosis factor blockers etanercept, infliximab and adalimumab». J Dermatolog Treat, 15, 5, setembre 2004, pàg. 280–94. DOI: 10.1080/09546630410017275. PMID: 15370396.
«Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases». Nat. Med., 9, 10, octubre 2003, pàg. 1245–50. DOI: 10.1038/nm939. PMID: 14520364.
«Cutting edge: anti-tumor necrosis factor therapy in rheumatoid arthritis inhibits memory B lymphocytes via effects on lymphoid germinal centers and follicular dendritic cell networks». J. Immunol., 180, 2, gener 2008, pàg. 688–92. DOI: 10.4049/jimmunol.180.2.688. PMID: 18178805.
«Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors». Acta Derm. Venereol., 89, 6, novembre 2009, pàg. 595–600. DOI: 10.2340/00015555-0747. PMID: 19997689.
Korneev, KV; Atretkhany, KN; Drutskaya, MS; Grivennikov, SI; Kuprash, DV; Nedospasov, SA «TLR-signaling and proinflammatory cytokines as drivers of tumorigenesis.». Cytokine, 89, gener 2017, pàg. 127–135. DOI: 10.1016/j.cyto.2016.01.021. PMID: 26854213.
«Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent». N. Engl. J. Med., 345, 15, octubre 2001, pàg. 1098–104. DOI: 10.1056/NEJMoa011110. PMID: 11596589.
«Invasive fungal infections in pediatric patients treated with tumor necrosis alpha (TNF-α) inhibitors». Mycoses, 60, 4, octubre 2016, pàg. 222–229. DOI: 10.1111/myc.12576. PMID: 27766695.
«TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.». Neurology, 53, 3, 11-08-1999, pàg. 457–65. DOI: 10.1212/WNL.53.3.457. PMID: 10449104.
Napolitano, M; Balato, N; Ayala, F; Cirillo, T; Balato, A «Multiple sclerosis following anti-tumor necrosis factor-alpha therapy for psoriasis: first case in Italy?». Giornale Italiano di Dermatologia e Venereologia, 153, 4, agost 2018, pàg. 567–572. DOI: 10.23736/S0392-0488.17.04992-6. PMID: 25692775.
Mansouri, B; Horner, ME; Menter, A «Tumor Necrosis Factor-α Inhibitor Use in Psoriasis Patients With a First-degree Relative With Multiple Sclerosis.». Journal of Drugs in Dermatology, 14, 8, agost 2015, pàg. 876–8. PMID: 26267733.
«Autoimmune encephalitis in humans: how closely does it reflect multiple sclerosis?». Acta Neuropathologica Communications, 3, 1, Dec 2015, pàg. 80. DOI: 10.1186/s40478-015-0260-9. PMC: 4670499. PMID: 26637427.
Lassman Hans «Acute disseminated encephalomyelitis and multiple sclerosis». Brain, 133, 2, Feb 2010, pàg. 317–319. DOI: 10.1093/brain/awp342. PMID: 20129937.
«The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-gamma». Critical Care Medicine, 34, 7, juliol 2006, pàg. 1874–82. DOI: 10.1097/01.CCM.0000221921.71300.BF. PMID: 16715036.
«Curcumin protects against radiation-induced acute and chronic cutaneous toxicity in mice and decreases mRNA expression of inflammatory and fibrogenic cytokines». Int. J. Radiat. Oncol. Biol. Phys., 65, 3, juliol 2006, pàg. 890–8. DOI: 10.1016/j.ijrobp.2006.03.025. PMID: 16751071.
«Effects of curcumin on tumour necrosis factor-alpha and interleukin-6 in the late phase of experimental acute pancreatitis». J Vet Med a Physiol Pathol Clin Med, 53, 1, febrer 2006, pàg. 49–54. DOI: 10.1111/j.1439-0442.2006.00786.x. PMID: 16411910.
«Alkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effects». J. Biol. Chem., 281, 20, maig 2006, pàg. 14192–206. DOI: 10.1074/jbc.M601074200. PMID: 16547349.
Vilcek, J «First demonstration of the role of TNF in the pathogenesis of disease.». Journal of Immunology, 181, 1, 01-07-2008, pàg. 5–6. DOI: 10.4049/jimmunol.181.1.5. PMID: 18566362.
